NasdaqGM - Delayed Quote • USD
LeMaitre Vascular, Inc. (LMAT)
At close: April 25 at 4:00 PM EDT
After hours: April 25 at 7:28 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
193,484.00
193,484.00
161,651.00
154,424.00
129,366.00
Cost of Revenue
66,435.00
66,435.00
56,755.00
53,042.00
44,748.00
Gross Profit
127,049.00
127,049.00
104,896.00
101,382.00
84,618.00
Operating Expense
89,852.00
89,852.00
74,960.00
64,957.00
56,300.00
Operating Income
37,197.00
37,197.00
29,936.00
36,425.00
28,318.00
Net Non Operating Interest Income Expense
3,077.00
3,077.00
986.00
-2,022.00
-1,103.00
Other Income Expense
-799.00
-799.00
-3,432.00
-116.00
141.00
Pretax Income
39,475.00
39,475.00
27,490.00
34,287.00
27,356.00
Tax Provision
9,370.00
9,370.00
6,854.00
7,380.00
6,136.00
Net Income Common Stockholders
30,105.00
30,105.00
20,636.00
26,907.00
21,220.00
Diluted NI Available to Com Stockholders
30,105.00
30,105.00
20,636.00
26,907.00
21,220.00
Basic EPS
1.36
--
0.94
1.27
1.05
Diluted EPS
1.34
--
0.93
1.25
1.04
Basic Average Shares
22,217.00
--
21,975.00
21,157.00
20,246.00
Diluted Average Shares
22,423.00
--
22,171.00
21,475.00
20,479.00
Total Operating Income as Reported
36,712.00
36,712.00
26,829.00
36,425.00
28,788.00
Total Expenses
156,287.00
156,287.00
131,715.00
117,999.00
101,048.00
Net Income from Continuing & Discontinued Operation
30,105.00
30,105.00
20,636.00
26,907.00
21,220.00
Normalized Income
30,475.06
30,475.06
22,969.36
26,907.00
20,855.28
Interest Income
3,077.00
3,077.00
986.00
197.00
207.00
Interest Expense
--
--
--
2,219.00
1,310.00
Net Interest Income
3,077.00
3,077.00
986.00
-2,022.00
-1,103.00
EBIT
39,475.00
39,475.00
27,490.00
36,506.00
28,666.00
EBITDA
48,990.00
48,990.00
36,923.00
47,576.00
37,061.00
Reconciled Cost of Revenue
66,435.00
66,435.00
56,755.00
53,042.00
44,748.00
Reconciled Depreciation
9,515.00
9,515.00
9,433.00
11,070.00
8,395.00
Net Income from Continuing Operation Net Minority Interest
30,105.00
30,105.00
20,636.00
26,907.00
21,220.00
Total Unusual Items Excluding Goodwill
-485.00
-485.00
-3,107.00
--
470.00
Total Unusual Items
-485.00
-485.00
-3,107.00
--
470.00
Normalized EBITDA
49,475.00
49,475.00
40,030.00
47,576.00
36,591.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-114.95
-114.95
-773.64
--
105.28
12/31/2020 - 10/19/2006
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ICUI ICU Medical, Inc.
94.53
-2.26%
MMSI Merit Medical Systems, Inc.
73.38
-0.88%
GXI.F Gerresheimer AG
99.80
-1.29%
1SXP.F SCHOTT Pharma AG & Co. KGaA
38.60
-1.08%
SKAN.SW SKAN Group AG
81.50
+0.62%
HAE Haemonetics Corporation
87.66
+1.67%
ATRC AtriCure, Inc.
22.61
-1.91%
KRMD KORU Medical Systems, Inc.
2.1900
-0.45%
TFX Teleflex Incorporated
206.71
-2.11%
MLSS Milestone Scientific Inc.
0.5700
+1.97%